Cassava Sciences, Inc.
(NASDAQ : SAVA)

( )
SAVA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. -3.70%80.802.1%$224.00m
SAVACassava Sciences, Inc. -0.51%9.710.0%$170.32m
JAZZJazz Pharmaceuticals Plc -0.01%138.052.4%$167.31m
HZNPHorizon Therapeutics Plc -5.58%75.335.8%$159.84m
MRNSMarinus Pharmaceuticals, Inc. -10.91%10.707.8%$120.24m
CORTCorcept Therapeutics, Inc. -1.67%16.785.5%$118.16m
VRXValeant Pharmaceuticals International, Inc. -3.24%15.2314.1%$89.62m
BHCBausch Health Cos., Inc. -3.24%15.230.0%$61.56m
MYOKMyoKardia, Inc. 0.49%130.021.8%$58.02m
ARGXargenx SE -1.13%243.070.0%$55.05m
AMRNAmarin Corp. Plc -1.09%3.641.5%$55.00m
SAGESAGE Therapeutics, Inc. -1.83%58.908.6%$45.77m
GWPHGW Pharmaceuticals Plc -1.50%98.506.2%$40.33m
AXSMAxsome Therapeutics, Inc. -2.14%75.931.9%$38.80m
PRGOPerrigo Co. Plc -0.90%44.966.8%$35.86m

Company Profile

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.